Nikstar

We can always do better, M.D, Part time AIM investor, research is key, wish everyone good luck

[Aston Martin Aramco F1 Team @AstonMartinF1]

That's P2 in Montréal! YES FERNANDO! 🤩

A mega drive from @alo_oficial secures second place and another podium at the #CanadianGP!

[Aston Martin @astonmartin]

“This is a lovely car to drive” - @alo_oficial.

Welcome to Aston Martin, Fernando.

A historic podium finish at the 2023 Bahrain GP.

110 years in the making.

#AstonMartin #INTENSITYDRIVEN

[Avacta @avacta]

Avacta Announces Successful Completion of Fourth Dose Escalation in AVA6000 Phase 1 Clinical Study. https://t.co/Q3S5ML1m3M #AVCT

[Phil Orford MBE @PhilOrford]

Thread

@BIVDA
@JolyonMaugham
@GoodLawProject
@JNHanvey
@emilydugan
@hannaheboland
@paulwaugh

Contents if this thread require investigation please
#ABDX #AVCT #ODX

1/n

[Nikstar @nikstar_aim]

@FirstSquawk Buy

[Avacta @avacta]

AffiDX® SARS-CoV-2 Antigen Lateral Flow Test Receives CE Mark for Consumer Self-Testing. https://t.co/oobWV69VTD #AVCT

[Neale Hanvey🏴󠁧󠁢󠁳󠁣󠁴󠁿 @JNHanvey]

@JimBethell Can I ask again for the comparative data that demonstrates this assertion.

I’ve been asking for over a year & lots of promises from Dr Harries, Jo Churchill & yourself, but no evidence.

Why did you break your promises to UK diagnostics companies?

Another scandal?

[Avacta @avacta]

Avacta Announces FDA Approval of its Investigational New Drug (IND) Application for AVA6000. https://t.co/wpgSh1CEoF #AVCT

[Avacta @avacta]

'Shaping the science of oncology'. Our CSO of Therapeutics Dr Fiona McLaughlin talks to @biosciencetoday about her mission to develop first and best-in-class cancer drugs. #AVCT https://t.co/gc9V1sloFX

[Michael Mina @michaelmina_lab]

Rapid tests work very well to answer 🧵
AM I INFECTIOUS and a RISK TO OTHERS

This is THE public health ? we care about

I made a BIG chart of rapid tests

- Overall sensitivity vs any PCR pos - what FDA judges

- Sensitivity if infectious (97%!) - what we actually care about

1/

[Avacta @avacta]

Avacta announces new appointments to the Scientific Advisory Board of its Therapeutics Division. https://t.co/xoF8tkMIMZ #AVCT

[Avacta @avacta]

Appointment of Dr Fiona McLaughlin as Chief Scientific Officer of Avacta’s Therapeutics Division. https://t.co/yzr7oZUB7i #AVCT

[The Citizens @allthecitizens]

🚨Breaking🚨
The UK government is dependent on imports of Rapid Antigen Tests (RATs) as a key part of its Test and Trace system, despite UK firms being ready and able to produce them, @allthecitizens can reveal with @bylinetimes / THREAD

[Avacta @avacta]

Avacta Announces First Patient Dosed in AVA6000 Pro-Doxorubicin Phase 1 Clinical Trial. https://t.co/qkRNKQj8p0 #AVCT

[Avacta @avacta]

Update on AffiDX® SARS-CoV-2 Antigen Lateral Flow Test. https://t.co/l0wPKf7R4r. #AVCT

[Avacta @avacta]

Avacta’s Diagnostic Division Achieves ISO 13485 Certification. #AVCT https://t.co/AWUkNGPPTh

[Avacta @avacta]

AffiDX® SARS-CoV-2 Antigen Lateral Flow Test Detects Delta Variant. #AVCT https://t.co/iTBFO4eF1L

[Avacta @avacta]

Registration of Avacta’s AffiDX® SARS-CoV-2 Antigen Lateral Flow Test in EU. #AVCT https://t.co/JK7PfkweWb

[Avacta @avacta]

For the latest product information on the AffiDX® SARS-CoV-2 Antigen Lateral Flow Test - including our product spec sheet, intended use, features / benefits and ordering information, visit: https://t.co/Wm3YFastYJ